Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,689 public trials 1,036 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

NCT05277051

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +49 more
Locations
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
  • GSK Investigational Site Oklahoma City, Oklahoma, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer

NCT05132075

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Valley Medical Center Research Renton, Washington, United States
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site Pilar, Buenos Aires, Argentina
  • Novartis Investigative Site Auchenflower, Queensland, Australia
View all 51 locations
View Trial Details
Active, Not Recruiting

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

NCT05555732

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Southern Cancer Center Pc Daphne, Alabama, United States
  • Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Arizona Oncology Associates, Pc - Nahoa Prescott Valley, Arizona, United States
  • Hoag Memorial Hospital Prebyterian Newport Beach, California, United States
View all 260 locations
View Trial Details
Active, Not Recruiting

Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

NCT05609578

Conditions
Advanced NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Local Institution - 017-936C Fountain Valley, California, United States
  • Local Institution - 017-936 Fountain Valley, California, United States
  • Local Institution - 017-851 Fullerton, California, United States
  • Local Institution - 017-540 San Francisco, California, United States
View all 94 locations
View Trial Details
Active, Not Recruiting

Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC

NCT06219317

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • CHU Helora Pole Hospitalier Jolimont Haine-Saint-Paul, Belgium
  • CHU Mont Godinne - UCL Namur Yvoir, Belgium
  • CH de La Cote Basque - Saint Leon Bayonne, France
View Trial Details
Active, Not Recruiting

Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status

NCT05673187

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Instiute Jules Bordet Brussels, Belgium
  • Le Mans - CHG Le Mans, France
  • Hôpital de Marseille Marseille, France
  • Beaumont Hospital Dublin, Ireland
View all 18 locations
View Trial Details

Related conditions